gov lk

All Market Authorization Holders,

You are hereby informed that all the operations related to Accepting dossiers/application and issuing certificates/licenses will not function on 15th April 2024 and will recommence from 16th April 2024.

Dear Valued Stakeholders,

We are pleased to inform you that effective from April 9, 2024, key divisions of the National Medicines Regulatory Authority have relocated to a new address. This move is part of our commitment to enhance efficiency and better serve our stakeholders.

New Location:

Engineering Corporation Building, No.130, W.A.D Ramanayake Mawatha, Colombo 02.

Divisions Relocated:

  • Medicine Regulatory Division
  • Medical Device Regulatory Division
  • Borderline Regulatory Division
  • Cosmetics Regulatory Division
  • Manufacturing Regulatory Division
  • Clinical Trial Regulatory Division
  • Pharmacovigilance Division
  • Pricing Unit

Operational Details:

  • Dossier Acceptance and Letter Receiving/Issuing Counters will also operate in the new location.
  • The National Medicines Quality Assurance Laboratory (NMQAL) will remain at its previous location on 120, Norris Canal Road, Colombo 10.

 

We kindly request all stakeholders to update their records and direct any correspondence to the new address.

Chief Executive Officer

National Medicines Regulatory Authority

We would like to inform you that the following divisions of the National Medicines  Regulatory Authority (NMRA) has relocated to the below mentioned address from February  2024. 

Divisions:  

  • Law enforcement division 
  • Pharmacy Regulatory division 
  • Finance division 
  • HR & Administrative division 
  • Legal division 
  • ICT division 

 

Relocated address:  

National Medicines Regulatory Authority 
State Engineering Corporation Building (2nd Floor) 
No. 130, W.A.D Ramanayaka Mawatha, 
Colombo 02. 

Phone numbers of the relocated divisions will be communicated in due course and e-mail  addresses remain unchanged. 

Chairman office, CEO office and other regulatory divisions are also to be relocated to this  location in near future. 

We sincerely apologise for any inconvenience this may cause. 

Dr. Saveen Semage 
Chief Executive Officer 

As the National Medicines Regulatory Authority, we are bound for offering effective service for the benefit of patients, and offering regulation and supervision to ensure the quality, safety and efficacy of medicines and healthcare products.  

Accepting bribes, giving bribes or corruption is a punishable offence.

Please let us know if you have not received efficient service from the National Medicines Regulatory Authority or if you have been inconvenienced in any way, or if you have any complaints regarding bribery, delays, lapses, or any suggestions / comments that you have.

Please scan the QR code given below, and fill the Google Form.  

QR code

As per the approval of the Board of Directors, the Arbiration committee has been established in order to provde unbiased and fair decisions for the appeals received by the NMRA without unnecessary delay. As such, the NMRA has provided the opportunity to submit appeals for concerns regarding regulatory decisions.

Appeal should be addressed to :  Chairman / Chief Executive Officer

Address                                     :  120, Norris Canal Road, Colombo 10

Contact Number                        :  0112303156 / 0112695173

Email                                         :   This email address is being protected from spambots. You need JavaScript enabled to view it. 

ජාතික ඖෂධ නියාමන අධිකාරියේ සහකාර ඖෂධ පරීක්ෂක තනතුර සඳහා වසර 01ක කාලයකට කොන්ත්‍රාත් පදනම මත බඳවා ගැනීමට සුදුසුකම් ලත් ශ්‍රී ලාංකීය පුරවැසියන්ගෙන් අයදුම්පත් කැඳවනු ලැබේ.

ජාතික ඖෂධ නියාමන අධිකාරිය කොළඹ පමණක් පිහිටා ඇති අතර වෙනත් ශාඛා කාර්යාල නොමැති බැවින් ස්ථාන මාරු වීම් රහිත වේ.

සහකාර ඖෂධ පරීක්ෂක (කොන්ත්‍රාත්) : (පුරප්පාඩු ගණන 05 යි)

  • සුදුසුකම්:

    • බාහිර අයදුම්කරුවන් :-

      විශ්වවිද්‍යාල ප්‍රතිපාදන කොමිෂන් සභාව විසින් පිළිගත් නීතිවේදී/ විද්‍යාවේදී/ මහජන සෞඛ්‍ය/ ජීව විද්‍යාව/ භෞතික විද්‍යාව/ ආහාර විද්‍යාව /ඖෂධවේදය හෝ තනතුරට අදාළ විෂය ක්ෂේත්‍රයේ වෙනත් උපාධියක් ලබා තිබීම.

  • මාසික කොන්ත්‍රාත් වැටුප :-

    MA 5-1 -2016 වැටුප් පරිමාණයේ ආරම්භක වැටුප් පියවර වන රු.34,870/- හා අනුමත දීමනා

  • වයස :-

    අවුරුදු 22ට නොඅඩු විය යුතු අතර අවුරුදු 45ට නොවැඩි විය යුතුය

  • බඳවා ගැනීමේ ක්‍රමය :-

    පත්වීම් බලධරයා විසින් පත් කරනු ලබන මණ්ඩලයක් විසින් පවත්වනු ලබන වෘත්තීය හා ව්‍යුහගත සම්මුඛ පරීක්ෂණයක ප‍්‍රතිඵල මත තෝරා ගැනීමෙන් පසු III ශ්‍රේණියට බඳවා ගනු ලැබේ.

වෙනත් කරුණු :-

සෑම ඉල්ලුම්කරුවක් ම,

  1. ශ්‍රී ලංකා පුරවැසියෙකු විය යුතුය.
  2. තනතුරට පැවරෙන කාර්යයන් මැනවින් ඉටු කිරීම සඳහා මෙන්ම දිවයිනේ ඕනෑම ප්‍රදේශයක සේවය කිරීම සඳහා අවශ්‍ය වන කායික හා මානසික යෝග්‍යතාවයෙන් යුක්ත විය යුතුය.
  3. විශිෂ්ට චරිතයෙන් යුක්ත විය යුතුය.

• රාජ්‍ය, අර්ධ රාජ්‍ය ආයතනවල සේවයේ නියුතු අයදුම්කරුවන් තම ආයතන ප්‍රධානියා මඟින් අයදුම්පත් යොමු කල යුතුය.

නිවැරදිව සම්පූර්ණ කරන ලද අයදුම්පත් 2024.06.03 දිනට හෝ එදිනට පෙර ලැබෙන සේ This email address is being protected from spambots. You need JavaScript enabled to view it. යන විද්‍යුත් ලිපිනයට ඊ-මේල් කිරීම මඟින් යොමු කල යුතුය. අයදුම්පත් යොමු කිරීමේදී විෂය ලෙස අයදුම් කරන තනතුර සඳහන් කල යුතුය.

සභාපති,

ජාතික ඖෂධ නියාමන අධිකාරිය.


CV format

 

සැළකිය යුතුයි:-

අදාළ ආකෘතියට අනුව පමණක් අයදුම්පත්‍රය සම්පූර්ණ කර එවිය යුතු අතර ඔබගේ අධ්‍යාපන හා වෘත්තීය සුදුසුකම් සනාථ කෙරෙන සහතිකපත්‍ර වල පිටපත් අයදුම්පත්‍රය සමඟ යොමු කල යුතු වේ. මෙම ආකෘතියට අනුව සම්පූර්ණ නොකරන ලද අයදුම්පත්, අසම්පූර්ණ අයදුම්පත් හෝ අයදුම්පත් භාර ගන්නා අවසන් දිනට සුදුසුකම් සම්පූර්ණ කර නොමැති අයදුම්පත් ප්‍රතික්ෂේප කරනු ලැබේ.

 

This is to convey that the National Medicines Regulatory Authority has taken following decisions after reassesing the prevailing situation in the country due to COVID 19.

1. To extend the validity of certificates of registration and import licenses pertaining to Medicines, Medical devices, Borderline products and Cosmetics up to 30th June 2021. The extension is applicable for certificates and licenses expiring after 30th June 2019. The decision was taken in order to minimize the movement of peaople. The decision would be reassesed again on or before 30th June 2021.

2. To grant approval to import & clear the above-mentioned products, at least twelve (12) months of shelf life to be retained, with the product at the time of importing until 30th June 2021. For parenterals, at least tweleve (12) months of shelf life to be retained, with the product at the time of importing. For vaccines prior approval to be required from the NMRA if the shelf life is below than the 66%.

As such there is no requirement for the NMRA to consider individual requests in this regard.

Please note the attched letter supersedes our previous communication letters on above subject matter.

 

It is hereby noticed that, after reassessing the prevailing situation in the country due to COVID 19 pandemic, the National Medicines Regulatory Authority has decided to extend the validity of certificates of registration, manufacturing and import licenses pertaining to Medicines, Medical Devices, Borderline Products and Cosmetics up to 30 th June 2021. The extension is applicable for certificates and licenses expiring after 30th of June 2019 or would be expired up to 30 th June of 2021.

The decision was taken in order to minimize the movement of people considering the prevailing situation in the country due to Covid 19 pandemic. The decision was taken in order to minimize the movement of people. The decision would be reassessed again on or before 30 th June 2021.

As such you are kindly requested to refrain from coming to NMRA premises except for an urgent matter.

It is hereby notified that, as per the legal requirement stated in the National Medicines (Registration and Licensing of Medicine) Regulations, 2019 published on 14.10.2019 by gazette bearing No.2145/01, all manufacturers/importers are required to provide details of Authorized Regulatory Affairs Officer/s (name of the authorized officer, name of the company, NIC number, contact details etc.) in your respective organizations responsible for documents pertaining to registration of medicines, manufacturing licenses, technical matters, and other correspondence with the Authority to the NMRA on or before 17th of November 2020.

Access to the NMRA premises will only be given to such Authorized Officers after 17th of November.

The National Medicines Regulatory Authority intended to extend the validity of certificate of registration, Manufacturing and import licenses pertaining to Medicines, Medical Devices, Borderline products and Cosmetics which have been expired after 30th of June 2019 or would be expired June up to 30th of 2021.

The decision was taken in order to minimize the movement of people considering the prevailing situation in the country due to COVID 19 pandemic. The decision would be reassessed on or before 30th June 2021.

120, Norris Canal Road, Colombo 10
 011-2687743
 info@nmra.gov.lk